Last reviewed · How we verify

NCT03252392

/Autism Spectrum Disorder(ASD)Hearing Abnormalities Study

Status unknown Last updated 17 August 2017
What this trial tests

trial in Autism Spectrum Disorder in 80 participants. Status unknown.

Timeline
1 October 2017
Primary endpoint
1 October 2020
1 October 2020

Quick facts

Lead sponsorAssiut University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment80
Start date1 October 2017
Primary completion1 October 2020
Estimated completion1 October 2020

Conditions studied

Sponsor

Assiut University

Who can join

Adults 3 to 12, any sex, with Autism Spectrum Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Co morbidity rates of hearing loss in children with autism spectrum disorder are high and increasing. Investigators are aiming to: 1. evaluate peripheral auditory and brain stem auditory function in children with autism spectrum disorder. 2. compare communication capabilities in autistic children having hearing abnormalities and autistic children with normal hearing.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Autism Spectrum Disorder

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03252392.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing